Last updated 9 months ago
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
12 patients around the world
Available in Mexico
Asociación para Evitar la Ceguera en México
1Research sites
12Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
- All ocular criteria apply to the study eye unless otherwise noted. Age ≥ 18 years.All ocular criteria apply to the study eye unless otherwise noted. Subject is phakic or pseudophakic with a posterior chamber intraocular lens (lens in the bag or sulcus).All ocular criteria apply to the study eye unless otherwise noted. Symptomatic corneal edema associated with endothelial dysfunction which may be secondary to Fuchs' corneal dystrophy or pseudophakic bullous keratopathy.
- All ocular criteria apply to the study eye unless otherwise noted. Other corneal diseaseAll ocular criteria apply to the study eye unless otherwise noted. Anterior chamber intraocular lensAll ocular criteria apply to the study eye unless otherwise noted. Sutured or scleral-fixated intraocular lens.All ocular criteria apply to the study eye unless otherwise noted. Macular disease that in the investigator and/or sponsor's opinion would limit the ability of the subject to demonstrate improvement in BCVA.All ocular criteria apply to the study eye unless otherwise noted. History of refractive surgery.All ocular criteria apply to the study eye unless otherwise noted. History of VitrectomyAll ocular criteria apply to the study eye unless otherwise noted. Descemet membrane detachment.All ocular criteria apply to the study eye unless otherwise noted. History of uveitis or other ocular inflammatory disease.All ocular criteria apply to the study eye unless otherwise noted. History of incisional glaucoma surgery (e.g.,trabeculectomy, glaucoma drainage implant).All ocular criteria apply to the study eye unless otherwise noted. IOP >21 or <7 mm HgAll ocular criteria apply to the study eye unless otherwise noted. Prior incisional eye surgery within 3 months prior to study treatment or penetrating or endothelial keratoplasty.All ocular criteria apply to the study eye unless otherwise noted. History of ocular neoplasm.All ocular criteria apply to the study eye unless otherwise noted. ETDRS BCVA in the fellow eye is worse than 35 letters (Snellen equivalent of 20/200).Female who is pregnant, nursing, or planning to become pregnant, or who is of childbearing potential and not using a reliable means of contraception during the study.Subject is currently participating in or has participated within the last 3 months in any other clinical trial of an investigational drug by ocular or systemic administration.Any concomitant medical or psychological condition that could interfere with study participation or is otherwise not suitable for entry into the study in the opinion of the investigator.
Sites
APEC - Hospital de la Ceguera
Recruiting
SponsorAsociación para Evitar la Ceguera en México
Study typeInterventional
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05636579
